CVS Health Corporation (CVS)

CVS Health Stock Forecast

Stock Price Forecast

According to 18 professional analysts, the 12-month price target for CVS Health stock ranges from a low of $70 to a high of $102. The average analyst price target of $87.72 forecasts a 15.99% increase in the stock price over the next year.

Price Target: $87.72 (+15.99%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$70	$87.72	$89	$102
Change	-7.44%	+15.99%	+17.68%	+34.87%

Analyst Ratings

The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	5	5	6	7	6
Buy	8	11	11	11	11	11
Hold	3	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	16	17	18	19	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lance Wilkes Bernstein	Bernstein	Hold Maintains $77 → $86	Hold	Maintains	$77 → $86	+13.71%	Dec 5, 2025
Stephen Baxter Wells Fargo	Wells Fargo	Buy Maintains $103 → $102	Buy	Maintains	$103 → $102	+34.87%	Nov 13, 2025
Charles Rhyee TD Cowen	TD Cowen	Strong Buy Maintains $99 → $100	Strong Buy	Maintains	$99 → $100	+32.22%	Nov 3, 2025
Elizabeth Anderson Evercore ISI Group	Evercore ISI Group	Buy Maintains $85 → $95	Buy	Maintains	$85 → $95	+25.61%	Oct 30, 2025
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $81 → $93	Buy	Maintains	$81 → $93	+22.97%	Oct 30, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

402.82B

Increased by 8.68%

from 370.66B

Revenue Next Year

423.18B

Increased by 5.05%

from 402.82B

EPS This Year

6.67

Increased by 82.11%

from 3.66

EPS Next Year

7.22

Increased by 8.31%

from 6.67

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	267.91B	290.91B	321.63B	356.62B	370.66B	402.82B	423.18B
Revenue Growth	4.75%	8.59%	10.56%	10.88%	3.94%	8.68%	5.05%
EPS	5.46	6.02	3.26	6.47	3.66	6.67	7.22
EPS Growth	7.54%	10.19%	-45.85%	98.47%	-43.43%	82.11%	8.31%
Forward PE	-	-	-	-	-	11.35	10.48
No. Analysts	-	-	-	-	-	30	29

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	422.6B	459.5B
Avg	402.8B	423.2B
Low	389.6B	393.8B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	14.0%	14.1%
Avg	8.7%	5.1%
Low	5.1%	-2.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	7.04	7.88
Avg	6.67	7.22
Low	6.10	6.48

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	92.2%	18.2%
Avg	82.1%	8.3%
Low	66.5%	-2.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.